Skip to main content
VASO
OTC Industrial Applications And Services

VASO Corp Reports Narrowed Q1 Loss Amidst Critical Cash Burn and 37% Drop in Reserves

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Health Tech Stocks · Healthcare
Sentiment info
Negative
Importance info
8
Price
$0.231
Mkt Cap
$40.68M
52W Low
$0.105
52W High
$0.247
52W Position info
120% above low
Off High info
6.4% below high
Rel. Volume info
8.9× avg
Market data snapshot near publication time

VASO has more than doubled off its 52-week low of $0.105 on elevated volume (8.9× avg).

Summary

VASO Corp reported a narrowed net loss and increased deferred revenue in Q1 2026, but faced a severe cash crunch with a $12.6 million operating cash burn and a 37% drop in cash reserves, raising significant liquidity concerns.


Key Events · Earnings and Guidance · VASO

  • Significant Cash Burn from Operations

    Net cash used in operating activities surged to $12.6 million in Q1 2026, a substantial increase from $0.57 million in Q1 2025.

  • Cash Reserves Decline

    Cash and cash equivalents dropped by 37% to $22 million at March 31, 2026, from $35 million at December 31, 2025.

  • Narrowed Net Loss

    The company reported a net loss of $0.89 million for Q1 2026, an improvement from a $1.08 million loss in the prior year's quarter.

  • Increased Deferred Revenue

    Deferred revenue grew to $39.5 million, with $103 million in unfulfilled performance obligations, indicating future revenue potential.


Analysis · VASO · Industrial Applications And Services

This quarterly report presents a mixed financial picture. While VASO Corp narrowed its net loss and saw an increase in deferred revenue, indicating some operational improvements and a future sales pipeline, the dramatic increase in cash used in operating activities and the subsequent 37% decline in cash reserves are critical concerns. For a company of this size, a $12.6 million quarterly cash burn is substantial and raises significant questions about its long-term liquidity, despite management's assertion of sufficient cash flow for the next twelve months. The high reliance on GE HealthCare for revenue and receivables also highlights a significant customer concentration risk.

At the time of this filing, VASO was trading at $0.23 on OTC in the Industrial Applications And Services sector, with a market capitalization of approximately $40.7M. The 52-week trading range was $0.11 to $0.25. This filing was assessed with negative market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

VASO - Latest Insights

VASO
Jul 31, 2026, 5:01 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $0.1899
Real-time Price: $0.250 info
Change: +$0.0601 (+32%) info
Market Cap: $44M info
VASO
May 15, 2026, 9:00 AM EDT
Source: GlobeNewswire
Importance Score:
8
Price at Filing: $0.18855
Real-time Price: $0.250 info
Change: +$0.06145 (+33%) info
Market Cap: $44M info
VASO
May 08, 2026, 4:01 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $0.17983
Real-time Price: $0.250 info
Change: +$0.07017 (+39%) info
Market Cap: $44M info
VASO
Apr 16, 2026, 9:03 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $0.1664
Real-time Price: $0.250 info
Change: +$0.0836 (+50%) info
Market Cap: $44M info
VASO
Apr 10, 2026, 9:29 AM EDT
Filing Type: SCHEDULE 13D
Importance Score:
8
Price at Filing: $0.1648
Real-time Price: $0.250 info
Change: +$0.0852 (+52%) info
Market Cap: $44M info